-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME2021-11-05
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 20212021-11-03
-
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH SILENCE THERAPEUTICS2021-10-15
-
VOLUNTARY ANNOUNCEMENT - LICENSING AGREEMENT WITH OLIX PHARMACEUTICALS2021-10-12
-
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL NOTICE OF“HS-10381 CAPSULES”2021-10-11
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 20212021-10-07
-
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF“PEG SIHEMATIDE INJECTIONS”ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION2021-10-04
-
ANNOUNCEMENT IN RELATION TO RESIGNATION OF NON-EXECUTIVE DIRECTOR2021-09-06
-
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS2021-09-06
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 20212021-09-03
-
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 20212021-08-26
-
DATE OF BOARD MEETING2021-08-16
